Page last updated: 2024-11-02

phenylbutazone and Armstrong Syndrome

phenylbutazone has been researched along with Armstrong Syndrome in 2 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MALLOULABRADOR, A1
LENG-LEVY, J1
DAVID-CHAUSSE, J1
LAGOARDE, J1
LATAPIE, JL1

Other Studies

2 other studies available for phenylbutazone and Armstrong Syndrome

ArticleYear
[PHENYLBUTAZONE THERAPY IN THE TREATMENT OF LYMPHOCYTIC MENINGITIS].
    Progresos de pediatria y puericultura, 1964, Volume: 7

    Topics: Child; Drug Therapy; Lymphocytic Choriomeningitis; Meningitis; Phenylbutazone

1964
[The treatment of acute benign lymphocytic meningitis by phenylbutazone].
    Journal de medecine de Bordeaux et du Sud-Ouest, 1962, Volume: 139

    Topics: Humans; Lymphocytic Choriomeningitis; Phenylbutazone

1962